| topic |  | | | title / date / summary | sort by date |
|---|
|
| no topic | | | | Nymox Signs New Sales and Marketing Agreement for Alzheimer's Test with Kyung Min Meditech Co. Ltd. In Korea
posted: Jun 14, 2006
June 14, 2006: Nymox announced today that it has entered into an agreement with Kyung Min Meditech Co., Ltd.
for the marketing and sale of the Company's AlzheimAlert™ kit in the Korea Republic. |
| no topic | | | | Nymox Reports Completion of NX-1207 Dosing in Current Multi-Center BPH Drug Trial
posted: Jun 9, 2006
June 9, 2006: Nymox announced today that patient dosing in the Company's multi-center Phase 2 clinical trial
of NX-1207 is completed this week. NX-1207 is Nymox's lead drug candidate for the treatment of benign prostatic hyperplasia (BPH), a common affliction of men over the age of 50. |
| no topic | | | | Long Term Statin Drug Use Safe According to Safety Task Force
posted: May 1, 2006
May 1, 2006: A recent comprehensive review by the Statin
Safety Task Force of the National Lipid Association confirmed that statins, a class of
drugs widely used for lowering cholesterol, are safe. Nymox
holds U.S. and global patent rights for the use of statin drugs for the prevention and
treatment of Alzheimer's disease. |
| AlzheimAlert™ & Diagnosis of Alzheimer's Disease | | | | Expert Review of Molecular Diagnostics Publishes Positive Report on Nymox Alzheimer Test
posted: Jan 9, 2008
January 9, 2008: Nymox announces the publication of a positive peer-reviewed paper on the clinical utility of the Company’s AlzheimAlert™ urine test as an aid to physicians in the diagnosis of Alzheimer’s disease in the current issue of Expert Review of Molecular Diagnostics (January 2008; 8:21-28). |
| AlzheimAlert™ & Diagnosis of Alzheimer's Disease | | | | Journal of Clinical Laboratory Analysis Publishes Positive New Data Bolstering Nymox’s AlzheimAlert™ Urine Test for Alzheimer’s Disease
posted: Jan 25, 2007
January 25, 2007: Nymox is pleased to announce the publication of a new peer-reviewed report in the most recent issue of the Journal of Clinical Laboratory Analysis providing further positive data on the accuracy and utility of the Company's urinary AlzheimAlert™ test. |
| AlzheimAlert™ & Diagnosis of Alzheimer's Disease | | | | Nymox Protein Biomarker for Alzheimer's is Years Ahead of Competition
posted: Dec 13, 2006
December 13, 2006: Nymox's AlzheimAlert™ test is literally years ahead of the competition, according to Brian Doyle, Nymox's Senior Manager for Worldwide Sales and Marketing. The urine-based test, which measures levels of a protein-based biomarker for Alzheimer’s disease, is currently available to physicians in major markets, including Europe and the United States. |
| AlzheimAlert™ & Diagnosis of Alzheimer's Disease | | | | Journal of the American Medical Directors Association Publishes Positive Independent National Study of Nymox's AlzheimAlert™ Urine Test For Alzheimer's Disease
posted: Oct 4, 2006
October 4, 2006: Nymox announces the publication of a peer-reviewed report on the successful results
of a multi-center double blind independent clinical study of the Company's urinary
AlzheimAlert™ test in the Journal of the American Medical Directors Association. |
| AlzheimAlert™ & Diagnosis of Alzheimer's Disease | | | | Nymox AlzheimAlert™ Independent Clinical Trial Data To Be Presented at the XXVIIIth International Congress of Clinical Neurophysiology
posted: Aug 23, 2006
August 23, 2006: Independent clinical trial results from studies of Nymox's AlzheimAlert™ test will be presented at the XXVIIIth International Congress
of Clinical Neurophysiology in Edinburgh, Scotland on September 11, 2006. The presentation
will concern the use of the AlzheimAlert™ test in the diagnosis of mild cognitive
impairment in the elderly. |
| AlzheimAlert™ & Diagnosis of Alzheimer's Disease | | | | Nymox AlzheimAlert™ Findings To Be Presented at the XXVIIIth International Congress of Clinical Neurophysiology
posted: May 17, 2006
May 17, 2006: Nymox is pleased to announce that positive results from successful clinical studies of the
Company's AlzheimAlert™ test will be presented at the upcoming International Congress
of Clinical Neurophysiology to be held in Edinburgh, UK from September 10 to 14, 2006. |
| AlzheimAlert™ & Diagnosis of Alzheimer's Disease | | | | Nymox AlzheimAlert™ Findings To Be Presented at the 4th Bologna International Meeting on Affective, Behavioral and Cognitive Disorders in the Elderly
posted: May 10, 2006
May 10, 2006: Nymox is
pleased to announce that positive results from successful clinical studies of the Company's AlzheimAlert™ test will be presented at the 4th Bologna International Meeting on Affective, Behavioral and Cognitive Disorders in the Elderly to be held in Bologna, Italy from June 15 to 17, 2006. |